Cargando…
Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B
Patients who are carriers of the hepatitis B virus (HBV) are at high risk of chronic liver disease (CLD) which proceeds from hepatitis, to fibrosis, cirrhosis and to hepatocellular carcinoma (HCC). The hepatitis B-encoded X antigen, HBx, promotes virus gene expression and replication, protects infec...
Autores principales: | Feitelson, Mark A., Arzumanyan, Alla, Spector, Ira, Medhat, Arvin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496119/ https://www.ncbi.nlm.nih.gov/pubmed/36140311 http://dx.doi.org/10.3390/biomedicines10092210 |
Ejemplares similares
-
Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma
por: Medhat, Arvin, et al.
Publicado: (2021) -
Epigenetic repression of E-cadherin expression by Hepatitis B virus x Antigen (HBx) in liver cancer
por: Arzumanyan, Alla, et al.
Publicado: (2011) -
Short-chain fatty acids in cancer pathogenesis
por: Feitelson, Mark A., et al.
Publicado: (2023) -
Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice
por: McBrearty, Noreen, et al.
Publicado: (2021) -
Hepatitis B Virus Oncoprotein HBx Is Not an ATPase
por: Langton, Michelle, et al.
Publicado: (2020)